Latest News Mar 17, 2023 5 most promising Fintech startups This is placeholder text. To change this content, double-click on the element and click Change Content. Read More Mar 21, 2023 Gadget review: release of new Airy Pods This is placeholder text. To change this content, double-click on the element and click Change Content. Read More Mar 22, 2023 Best smart wearables of 2023 This is placeholder text. To change this content, double-click on the element and click Change Content. Read More Mar 19, 2023 How technology can help curb attention disorders This is placeholder text. To change this content, double-click on the element and click Change Content. Read More Mar 18, 2023 Entering a new era of IoT This is placeholder text. To change this content, double-click on the element and click Change Content. Read More Mar 20, 2023 Long-term benefits of clean energy sources This is placeholder text. To change this content, double-click on the element and click Change Content. Read More

tVNS® vagus therapy devices offer a non-surgical neuromodulation treatment option by providing auricular vagus nerve stimulation in difficult-to-treat brain diseases with the help of a smartphone-sized device and a special electrode. tVNS® Devices for Patients Be a part of your success story Buy tVNS Better days are ahead EU-MDR Cla ss IIa Certified Medical Device tVNS® is the world's only non-invasive vagus nerve stimulation approved as a Class IIa medical device under the EU-MDR, offering a scientifically validated treatment for conditions related to sympathovagal imbalance. Non-Invasive Approach A safe and gentle alternative to surgery and medication, tVNS® stimulates the vagus nerve through the skin, offering a harmonious path to wellbeing with very low side-effects. Most Effective Stimulation Site Minimal Side Effects tVNS® is the only non-invasive stimulation device that stimulates the cymba concha, resulting in 100% vagus nerve innervation (as opposed to e.g. the tragus, which only results in 45% innervation). Transitioning away from traditional medications often aims to reduce side effects. tVNS®, as a drug-free therapy, offers a safer alternative with lower risk of long-term adverse effects. tVNS® In the Media To play, press and hold the enter key. To stop, release the enter key. What is tVNS®? Navigating the world of medical treatments can be overwhelming, especially when faced with persistent and challenging health issues. Whether you’ve been tirelessly seeking effective solutions, or if traditional drug therapies have been unsuccessful, there is another option: tVNS® . The vagus nerve, central to our body’s nervous system, plays a critical role in maintaining homeostasis. tVNS®, or Transcutaneous Vagus Nerve Stimulation , harnesses the therapeutic potential of this nerve through targeted stimulation of its auricular branch, accessible within the ear. This innovative approach utilizes gentle electrical impulses to modulate the vagus nerve’s activity, encouraging a state of balance across the body’s systems. The result? A reduction in the symptoms of neurological diseases associated with sympathovagal imbalance, achieved through a method that avoids the invasiveness of surgery and the side effects associated with medication. Approved as a Class IIa medical device under the European Medical Device Regulation (MDR), tVNS® sets a new standard in the treatment of neurological conditions, offering a blend of efficacy, safety, and simplicity. Non-invasive vagus nerve stimulation for the treatment of neurological diseases tVNS® is indicated to treat the following conditions: ✓Depression ✓Epilepsy ✓Chronic Migraines ✓Prader-Willi Syndrome tVNS® Devices are Trusted by Leading Institutions Worldwide To play, press and hold the enter key. To stop, release the enter key. Why choose our tVNS® devices? Our tVNS® device is the only non-invasive vagus nerve stimulator that is approved as a Class IIa medical device under the European Medical Device Regulation (EU-MDR). tVNS® sets itself apart with its non-invasive, clinically validated approach, offering a safer and more comfortable alternative to invasive methods. Uniquely targeting the cymba concha for 100% innervation of the auricular branch of the vagus nerve (ABVN) with our patented electrode, tVNS® ensures maximum efficacy compared to other devices that only achieve partial innervation. EU-MDR Cla ss IIa Approved Medical Device Our tVNS® device is the only non-invasive vagus nerve stimulation (VNS) device that is approved as a medical device under the EU-MDR. It uniquely targets the Cymba Concha for 100% innervation of the auricular branch of the vagus nerve, unlike other devices that stimulate other areas and are not manufactured under the same quality and safety standards. EU-MDR Cla ss IIa Non-Surgical Approach tVNS® offers the efficacy of vagus nerve stimulation without the complexities or risks of surgical interventions. This means meaningful therapeutic benefits, all under your control, without invasive procedures. EU-MDR Cla ss IIa Minimal Side Effects Transitioning away from traditional medications often comes with the pursuit of fewer side effects. tVNS®, being drug-free, ensures a therapeutic experience with reduced potential for long-term adverse outcomes, positioning itself as a safer alternative. EU-MDR Cla ss IIa Made in Germany Our commitment to excellence ensures that each device meets the highest standards of quality and performance, embodying the renowned precision of German engineering and manufacturing. With tVNS®, you’re choosing a device built on a foundation of durability and innovative design, trusted by healthcare professionals and researchers worldwide. EU-MDR Cla ss IIa Innovative App Integration Tracking and understanding your treatment progression is crucial. Our dedicated tVNS® Patient App not only provides real-time monitoring but also facilitates seamless sharing of data with your healthcare professionals. EU-MDR Cla ss IIa Remote Flexibility In our modern age, the convenience of remote access is invaluable. tVNS® extends this by offering device delivery directly to your doorstep and remote training. Initiate your treatment journey without the hassles or constraints of travel. EU-MDR Cla ss IIa Pediatric Compatibility tVNS® has been meticulously designed and approved for use in children aged 3 and above, bridging a crucial gap in pediatric care. EU-MDR Cla ss IIa Easy to Use Functionality should not compromise simplicity. The tVNS® device, while technologically advanced, is as intuitive as a smartphone, making integration into daily routines effortless. How does tVNS® work? tVNS ® Patient Devices - tVNS ® E tVNS® vagus therapy devices offer a non-surgical neuromodulation treatment option by providing auricular vagus nerve stimulation in difficult-to-treat brain diseases with the help of a smartphone-sized device and a special electrode. With its innovative mobile application, the patient can share all the treatment information with a single click without leaving his home, and reach the necessary follow-up and support. tVNS® stimulates the branch of the vagus nerve in the auricle through the skin with gentle electrical impulses. Signals are passed on to the brain via special nerve fibers: first in the brain stem and then in higher centers. The treatment with tVNS® is applied by patients independently. It has been used by thousands of patients and is a treatment with very few side effects. Developed and manufactured in Germany, our devices meet the highest quality standards, reflecting our dedication to excellence and the well-being of our patients Download the tVNS® Patient App The innovative tVNS® Patient App is a wellness and session-diary application designed to help users keep a record of their well-being and the duration of their stimulation sessions. The tVNS® Patient App is available now in the Google Play Store and in the Apple App Store (EU-only). tVNS® Patient is fully compliant with the General Data Protection Regulation (GDPR), ensuring that patient data is handled with the utmost care and confidentiality. Clinical Evidence: The Science behind tVNS® Discover the proven effectiveness and safety of tVNS®, highlighted by pivotal clinical trials and studies. Our unique focus on cymba concha stimulation, quality control and clinical evidence, positions tVNS® as the preferred choice among researchers, ensuring we lead in neurotherapeutic innovation and patient care. Epilepsy After a 20 week treatment period, active tVNS® patients recorded an average 34.2% reduction of seizure frequency. Prader-Willi-Syndrome After a treatment period of 12 months, 80% of tVNS® patients recorded a reduction of mean number of outbursts per day of 50%, compared to mean number of outburst per day before treatment. Migraines Treatment with tVNS® led to a reduction of 50% of the frequency of days with migraines after a treatment period of 12 weeks. Depression tVNS® led to a reduction of depression-specific HAMD score of minimum 2-3 points in adult patients when used in parallel with psychopharmacological and psychotherapy treatments after a period of 9 weeks. tVNS Healing Stories Take the next step with tVNS® - for a life without limitations. Every day presents an opportunity. Yet, for those navigating the challenges of medical conditions, some days can feel overshadowed by discomfort or uncertainty. With tVNS® , we aim to bring a brighter shade to every day. By harnessing the power of neurostimulation, our tVNS® device aims to pave the way for more pain-free days, empowering patients to lead self-determined lives. It’s not merely about symptom relief, it’s about reclaiming the essence of each day, savoring moments with loved ones, and pursuing passions without being held back by your condition. tVNS® is approved for the treatment of the following indications. Anxiety Atrial Fibrillation Autism Cognitive Impairment Crohn's disease (IBD) Depression Epilepsy Migraine Parkinson's Prader-Willi Syndrome Sleeping disorders Systematic Sclerosis Tinnitus Contact Our Global tVNS Experts Worldwide Name : Select inquiry: Choose an option Email : Country Please enter you message here Code Phone (optional) I have read and agree to the Privacy Policy Send Thanks for submitting! Contact Our Global tVNS Experts Worldwide Name : Select inquiry Choose an option Email : Country Please enter you message here Code Phone (optional) I have read and agree to the Privacy Policy Send Thanks for submitting!

tVNS Health Gmbh is a medical technology sales company based in Grünwald, Germany, that has been responsible for the global distribution, services, and operations management of tVNS devices. tVNS® in Italy: tVNS Health GmbH | E. M. S. s. r. l tVNS Health GmbH is a medical technology sales company based in Germany, responsible for the global distribution, services, and sales of tVNS® non-invasive auricular vagus nerve stimulation devices in Eastern Europe, Scandinavia, Asia, Africa, South America and Italy. The developer and manufacturer of tVNS® devices is tVNS Technologies GmbH based in Erlangen, Germany. Since the medical approval of the Cerbomed Nemos® device as a first non-invasive auricular vagus nerve stimulation medical device in 2010, Cerbomed Nemos® and the new tVNS® have been used in thousands of treatments globally and significantly improved patients’ quality of life. E.M.S. s.r.l. is a commercial company founded in Bologna in 1994 and ISO-9001 certified. Specializing in the marketing of electromedical equipment and related software systems, the company has established itself as a reliable partner in the field of medical technology. With deep expertise in neuropsychology, neurology, neurorehabilitation, and neurosurgery, E.M.S. offers high-quality, innovative, and exclusive solutions. Thanks to its strong sales network and advanced organizational structure, the company serves both hospitals and neurophysiological research centers with products that exceed standard market quality. In Italy, E.M.S. s.r.l. is the official distributor of tVNS Health GmbH and tVNS Technologies GmbH , providing sales and support services for tVNS® devices and ensuring widespread access to neuromodulation treatments. tVNS Health GmbH Global Sales & Services: Südliche Münchner Str. 62, 82031 Grünwald, Germany info@tvns.health www.tvns.health E. M. S. s. r. l Distributor in Italy Via di Saliceto 81, 40128 Bologna Italy www.emsmedical.net Tel. +39-051396205 Contact Us

< Back Long-term benefits of clean energy sources Kim Jennings Mar 20, 2023 This is placeholder text. To change this content, double-click on the element and click Change Content. This is placeholder text. To change this content, double-click on the element and click Change Content. Want to view and manage all your collections? Click on the Content Manager button in the Add panel on the left. Here, you can make changes to your content, add new fields, create dynamic pages and more. Your collection is already set up for you with fields and content. Add your own content or import it from a CSV file. Add fields for any type of content you want to display, such as rich text, images, and videos. Be sure to click Sync after making changes in a collection, so visitors can see your newest content on your live site. Previous Next

tVNS treatment in sleep disorders. The most up-to-date health information on sleep disorders causes, symptoms, treatment options INSOMNIA (SLEEP DISORDER) What is Insomnia? Insomnia is a common sleep disorder that makes it difficult to fall asleep and stay asleep, or to wake up too early and not be able to go back to sleep. People with insomnia feel tired when they wake up. Insomnia can reduce not only energy level and mood, but also health, work performance and quality of life. It is the disease of not being able to sleep in sufficient time and restful sleep. During the existence of the disease, symptoms such as irregularity in sleeping hours, sudden night awakenings, difficulty falling asleep after waking up, and waking up very early in the morning are observed. The existence of a regular sleep time and long naps does not mean that we will wake up the next day rested and ready to work. In studies on sleep and sleeping problems, it is said that an adult individual should sleep 7-8 hours every night. However, the resting process, which differs from person to person, can change the person's sleep duration. Types of Insomnia Acute insomnia: It refers to the short-term appearance of insomnia. Acute insomnia usually occurs after a stressful day or on days when mental tension is high. Our body clock has a hard time showing when it's time to rest on such difficult days. This irregularity, which usually lasts for 1 to 2 days, continues unti l we feel better. There are signs of acute insomnia that can last up to 4 weeks. Chronic Insomnia: A sleep disorder that lasts for 1 month or more is called chronic insomnia. A large proportion of 10-15% of adults suffer from chronic insomnia. Compared to acute insomnia, chronic insomnia requires medical attention. The main cause of this type of disorder is usually the presence of major depression. Hypersomnia: characterized by excessive sleepiness and excessive daytime sleep requirements. It is less common than insomnia. Narcolepsy : Includes excessive daytime sleepiness and abnormal findings in daily REM sleep for at least 3 months. Narcolepsy is an abnormality in the sleep mechanism, especially in the REM mechanism. Treatment Options for Insomnia Sleep Techniques Airflow in and out of the lungs during breathing Blood oxygen levels. Body position. Brain waves (EEG) More information CPAP Titration (Mask Therapy) Some cases of severe depression require a hospital stay. This may be necessary in situations where the individual is unable to take care of themselves properly and is in danger of harming themselves or someone else. More information Polysomnography Sleep test. It is a process that is done by recording with the help of devices all night long to determine the quality of sleep and to find the cause of the sleep disorder. More information Transcutaneous Vagus Nerve Stimulation (tVNS) Communication between the gut and the brain is provided by the vagus nerve. More information WE DESIGN THE MEDICAL TECHNOLOGIES OF THE FUTURE Contact us

tVNS non-surgical tvns treatment for cognitive impairment, dementia and alzheimer's. The most up-to-date health information on cognitive impairment causes, symptoms, and treatment options Cognitive Impairment Groundbreaking Technologies for Life What is Cognitive Impairment? The shrinkage caused by the loss of cells in the brain causes various functional disorders. These dysfunctions may manifest as dementia, Alzheimer, and mild cognitive impairment, which are comm on in people ives. People with cognitive impairment are at high risk for Alzheimer and dementia. When adequate precautions are taken, cognitive impairment may regress, and it is possible for these people to lead a normal life. Types of Cognitive Disorder Demantia It is the inadequacies experienced in language, skills and orientation, especially forgetfulness. Dementia is a family that includes many different types. There are Alzheimer's, dementia due to c hronic cerebrovascular disease, alcoholic dementia, depr essive dementia, dementia due to infections, etc. Dementia occurs as a result of general deterioration of the upper level functions of the cerebral cortex, especially over 75 years of age, with advancing age. There are dementias that start with memory impairment such as Alzheimer's disease, as well as behavioral disorders, skill disorders, depression, There are also dementias that start with the symptoms of parkinson's disease and language disorders. It is a progressive disease. Alzhemeir It is the most common type of dementia is a neurological disease that causes the destruction of brain cells. The disease, which causes a decrease in thought, memory and behavioral functions, occurs after a long time with advancing age. It may take years for the disease to reach advanced stages. Because it is a progressive disease, Alzheimer's patients experience problems such as inability to perform their daily tasks, forgetfulness and serious confusion. People with memory loss or other possible Alzheimer's symptoms may have trouble recognizing that they have a problem. Treatment Options for Cognitive Disorder There is no drug therapy approved to treat cognitive impairment. Medicines used to treat symptoms of Alzheimer's disease have been tried. Some studies have found that using these drugs for cognitive impairment is helpful, while others have concluded that there is no benefit. It has been noted that the use of other drugs, including NSAIDs, Ginkgo, Biloba and vitamin E, does not provide a great benefit. tVNS Effect Mechanism There are many clinical studies in recent years that cognitive disorders are caused by inflammation in the brain. Although the basic efficacy mechanism of tVNS has not been fully resolved, our new generation devices in 2021 became the first neuromodulation therapy approved for cognitive impairment in the world, due to both its benefits in the treatment of inflammation and the increase in neuroplasticity. Contact us

Available Services Service Name This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Service Name This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Service Name This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Service Name This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Service Name This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Service Name This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Contact Like what you see? Get in touch to learn more. First Name Last Name Email Message Send Thanks for submitting!

tVNS non-surgical, drug-free treatment with low side effects. The most up-to-date health information on the causes, symptoms, and treatment options of depression. Gain more freedom and self-determination. Treat depression with tVNS®. Depression Depression is a mood disorder that negatively affects the way one thinks and feels, interfering with one’s daily activities. It is characterized by a p ersistent feeling of sadness and hopelessness along with a loss of interest in activities that were once enjoyed. Treatment Options for Depression Medication There are different types of medications that can be used to treat depression including serotonin-norepinephrine reuptake inhibitors (SNRIs), selective serotonin reuptake inhibitors (SSRIs), Monoamine Oxidase Inhibitors (MAOIs), tricyclic and tetracyclic antidepressants, and many others. The doctor or pharmacist will inform patients about the possible mild or severe side effects of these drugs upon prescription, which will be followed by close monitoring for the first few weeks after starting the medication. Psychotherapy Psychotherapy is a general term for continuing treatment of depression which entails talking to a mental health professional about one’s condition and related issues. Psychotherapy is also known as talk therapy or psychological therapy. Different types of psychotherapy, such as cognitive behavioral therapy or trauma therapy, can be effective for depression depending on the patient. Hospital Treatment Some cases of severe depression requir e in-patient hospital stays. This may be necessary when the individual is unable to properly care for themselves and is in danger of harming themselves or others. Psychiatric treatment in a hospital can help an individual stay calm and safe until their mood improves. Partial hospital or day treatment programs may also help some individuals. Electroconvulsive therapy (ECT) In EC T, electrical currents are passed through the brain to impact the function and effect of neurotransmitters in your brain to relieve depression. ECT is usually used for people who don’t get better with medications, can’t take antidepressants for health reasons, or are at high risk of suicide. Transcranial magnetic stimulation (TMS) TMS may be an option for those who haven’t responded to antidepressants. During TMS, a treatment coil, placed against your scalp, sends brief magnetic pulses to stimulate nerve cells in your brain that are involved in mood regulation and depression. Transcutaneous Vagus Nerve Stimulation (tVNS) The tVNS® auricular vagus stimulation device is a treatment option that provides vagus nerve stimulation through the ear. The increase in parasympathetic activity from the stimulation provides relaxation and a calming effect. The increased release of serotonin provides a positive change in mood and the increased sleep quality leads to an improvement in the overall quality of life. Significant decreases in Hamilton Rating Scale for Depression, increase in Resting State Functional Connectivity and decrease in Beck Depression Inventory can be observed. tVNS® has very low side effects compared to drug options. tVNS® has helped many patients suffering from depression to reduce or completely eliminate their symptoms and lead a more self-determined and free life. Contact Us

Pioneering Neuromodulation Research with tVNS® Discover why tVNS® is the preferred device for research on transcutaneous vagus nerve stimulation.With its precise cymba concha stimulation and wireless parameter flexibility, tVNS offers cutting-edge technology and unparalleled flexibility to explore new therapeutic protocols.Approved under the EU-MDR and backed by CB reports, our tVNS device ensures adherence to the highest standards of safety and efficacy in medical research. tVNS® R for Research Transcutaneous Vagus Nerve Stimulation Device for Research Full Wireless Parameter Programmability Patient App for Data Collection Support for Clinical Trials Triggered tVNS® Legacy and Hook Electrode Sham Stimulation tVNS® Devices are Trusted by Leading Institutions Worldwide To play, press and hold the enter key. To stop, release the enter key. Why We Lead in Vagus Nerve Stimulation? For over 20 years, our commitment to innovation has positioned us at the forefront of non-invasive vagus nerve stimulation. Our unmatched research and development efforts are backed by solid clinical trials, ensuring our devices are not only effective but also safe and reliable. As an approved Class IIa medical device under the EU-MDR, we offer scientifically validated solutions in a market crowded with unverified alternatives. Since introducing the Cerbomed Nemos® device, we’ve led the market in non-invasive vagus nerve technology. Our pioneering approach and sustained innovation keep us ahead, with our devices being preferred by healthcare professionals and researchers worldwide due to unmatched safety, reliability and precision. Developed and manufactured in Germany, our devices meet the highest quality standards, reflecting our dedication to excellence and the well-being of our patients. Learn More About tVNS Health GmbH Why Choose our tVNS® Devices for Research? Our tVNS® device is the only non-invasive vagus nerve stimulator that is approved as a Class IIa medical device under the European Medical Device Regulation (EU-MDR). tVNS® sets itself apart with its non-invasive, clinically validated approach, offering a safer and more comfortable alternative to invasive methods. Uniquely targeting the cymba concha for 100% innervation of the auricular branch of the vagus nerve (ABVN) with our patented electrode, tVNS® ensures maximum efficacy compared to other devices that only achieve partial innervation. Introducing the tVNS® Triggerbox Launching December 1, 2024, the tVNS® Triggerbox advances neuromodulation research by providing a cable-bound system that minimizes latencies and enhances protocol reproducibility. This key advancement ensures precise, reliable experimental setups for cutting-edge studies. EU-MDR Cla ss IIa Approved Medical Device Our tVNS® E device is the only non-invasive vagus nerve stimulation (VNS) device that is approved as a medical device under the EU-MDR. The supporting comprehensive CB reports not only highlight our device’s safety and efficacy but also facilitate smoother approval processes for your research protocols by ethics committees. EU-MDR Cla ss IIa Cymba Concha Stimulation Benefit from our device’s electrode design, targeting the cymba concha, a method preferred by researchers for its 100% innervation of the auricular branch of the vagus nerve (ABVN). This targeted approach is designed to maximize therapeutic outcomes by engaging the vagus nerve more effectively than other non-invasive methods. EU-MDR Cla ss IIa Wireless Connectivity and Programmability Leverage the power of wireless technology for seamless operation and data management. The tVNS® Research app enables remote programming of stimulation parameters, providing the flexibility needed to adapt to the evolving needs of complex research protocols without interrupting the participant’s experience. EU-MDR Cla ss IIa Made in Germany Trust in the quality and reliability of a device that’s proudly designed and manufactured in Germany. Our commitment to excellence guarantees that every tVNS® device meets the highest standards of performance, durability, and safety, making it the ideal choice for institutions demanding the best in research equipment. EU-MDR Cla ss IIa Titanium-Iridium Electrode Our tVNS® device features titanium-iridium electrodes, most often used in implants and known for their biocompatibility, offering optimal stimulation with minimal irritation. This superior choice sets us apart from stainless steel alternatives, ensuring a more comfortable and effective treatment experience. EU-MDR Cla ss IIa GDPR-Compliant Data Processing With a commitment to privacy and security, our tVNS® system ensures that all data collected through the app is processed in strict adherence to the General Data Protection Regulation (GDPR). Researchers can collect, store, and analyze sensitive data with confidence, knowing that participant privacy is protected. EU-MDR Cla ss IIa Global Network of Trusted Institutions Join an esteemed community of researchers from leading universities and hospitals around the world who have chosen tVNS® for their studies in the global effort to advance neurological research and patient care. EU-MDR Cla ss IIa 20+ Years of Experience With over 20 years of dedicated research and development, we proudly developed the world's first approved non-invasive vagus nerve stimulator, the Cerbomed Nemos® device. Our deep-rooted expertise and pioneering spirit have established us as leaders in the field, committed to delivering groundbreaking and effective solutions for our patients. tVNS® for Research: An Overview Welcome to the frontier of vagus nerve stimulation research. Our tVNS® R device is designed for flexibility and precision, offering full wireless programmability for comprehensive clinical studies. With the tVNS® Research and tVNS® Patient apps, adjustment of stimulation parameters, data collection and patient feedback are seamlessly integrated, enhancing the scope and accuracy of your research. We are committed to facilitating your clinical trials and provide support for studies, including a comprehensive CB safety report for ethics approvals and access to a global network of experts. Explore the potential of tVNS® R to forge new paths in neurological research and patient care. Full Wireless Parameter Programmability and Triggered tVNS® With the tVNS® Research app, you have the capability to wirelessly adjust a comprehensive range of parameters including frequency, pulse width, current intensity, and stimulation intervals. In addition, we offer a separate PC-based tVNS® manager software. This software enables reaction to outside trigger signals (e.g. ECG R-wave trigger generated by an external ECG system, transferred to a PC). Thus, closed loop tVNS® or triggered tVNS® can be realized in a scientific setup. Precision in Research with the tVNS® Triggerbox The new tVNS® Triggerbox, launching December 1, 2024, marks a significant advancement in the field of tVNS® research. Designed in response to feedback from scientific communities, this device addresses the crucial need for more stable and reproducible stimulation protocols in tVNS®. By replacing Bluetooth connections with a cable-bound system, the tVNS® Triggerbox significantly reduces latencies and fluctuations, enabling precise synchronization with external trigger signals. This innovation not only enhances the reliability of experimental setups but also simplifies the integration with existing research frameworks, promising to push the boundaries of tVNS® research further. Research and Patient App Your tVNS® R device gives you access to two apps: the tVNS® Research and tVNS® Patient app. All technical parameters can easily be reprogrammed and wirelessly transmitted with the tVNS® Research app, allowing the researcher to try completely new stimulation protocols. In addition, you can collect and store technical and patient data. The tVNS® Patient app automatically stores all technical data (stimulation parameters, time and duration of the stimulation etc.) and offers a questionnaire for patient feedback. tVNS® Patient is fully compliant with the General Data Protection Regulation (GDPR), ensuring that patient data is handled with the utmost care and confidentiality. Customization and Support for Trials We offer an individual adaptation of all components of the device for certain studies, e.g by changing the questionnaire in order to allow better feedback from the patient, or through the implementation of special stimulation parameters or technical ideas. The tVNS® R device is defined as a device for investigational use. We can provide a CB report that proves the safety according to all medical device standards, in order to assist you with ethics approvals. So far, it has been accepted by all ethics committees. In addition, we offer an international expert network and can direct any questions to experienced people around the world. Legacy and Hook Electrode We offer two different types of electrode designs with our tVNS® devices: The Hook Electrode (left) allows for better fixation and usability during active tasks. It also allows patients to wear earphones. The Legacy Electrode (right) can be used if the patient has small ears or a special ear shape. The integrated slider allows for better adaption to the ear. Sham and fMRI Electrode Options The well-known sham-stimulation option at the earlobe is possible with our Legacy Electrode. Upon request, we also provide more sophisticated sham-stimulation options, as well as fMRI-compatible electrodes. Support for Clinical Trials We offer an individual adaptation of all parts for certain studies, e.g by changing the questionnaire in order to allow better feedback from the patient, or through the implementation of special stimulation parameters or technical ideas. The tVNS® R device is defined as a device for investigational use. We can provide a CB report that proves the safety according to all medical device standards, in order to assist you with ethics approvals. So far, it has been accepted by all ethics committees. In addition, we offer an international expert network and can direct any questions to experienced people around the world. Book a Personal Consultation with our Research Experts Contact our tVNS® Research Team to learn more about tVNS® and receive personalized information and support, such as CB Reports and Instructions for Use (IFU). Name : Select inquiry: Choose an option Email : Country Please enter you message here Code Phone (optional) I have read and agree to the Privacy Policy Send Thanks for submitting!

tVNS® is a transcutaneous vagus nerve stimulation device for the treatment of symptoms of sympathovagal imbalance. It is approved for epilepsy, autism, insomnia, tinnitus, cognitive impairment, depression and migraine. Changing the World Changing the Lives Elevate your health journey and discover a medication-free, low side effect and non-invasive therapy option for the treatment of neurological diseases. Time to meet a better version of your life. I'm a Patient I’m a Physician I’m a Researcher Become a Distributor Learn more about tVNS Health GmbH tVNS Health GmbH offers worldwide sales and solution services for tVNS® devices for the selected regions , ensuring widespread access to revolutionary neuromodulation treatments across the globe. To play, press and hold the enter key. To stop, release the enter key. tVNS® Devices are Trusted by Leading Institutions Worldwide Why We Lead in Vagus Nerve Stimulation? For over 20 years , our commitment to innovation has positioned us at the forefront of non-invasive vagus nerve stimulation. Our unmatched research and development efforts are backed by solid clinical trials, ensuring our devices are not only effective but also safe and reliable. As an approved Class IIa medical device under the EU-MDR , we offer scientifically validated solutions in a market crowded with unverified alternatives. Since introducing the Cerbomed Nemos® device, we’ve led the market in non-invasive vagus nerve technology. Our pioneering approach and sustained innovation keep us ahead, with our devices being preferred by healthcare professionals and researchers worldwide due to unmatched safety, reliability and precision. Developed and manufactured in Germany, our devices meet the highest quality standards, reflecting our dedication to excellence and the well-being of our patients. Discover tVNS Patient Discover tVNS Research tVNS® In the Media To play, press and hold the enter key. To stop, release the enter key. tVNS® Healing Stories News from tVNS® tVNS Coma Symposium, Warsaw, Poland "tVNS therapy in Comatose Patients" has been a focus research area in recent years in collaboration with esteemed scientists from... Transcutaneous Vagus Nerve Stimulation (tVNS) in Autism. Pediatric neurology specialist Associate Professor Dr. Barış Ekici shares his insights and experiences with transcutaneous vagus nerve stimu Information on tVNS from PD Dr Ranni von Wrede and Dr Pukrowski from Klinik für Epileptologie, UKB Bonn PD. Dr. Ranni von Wrede and Dr. Pukrowski, leading epileptologists from the University of Bonn, discuss the concept of Transcutaneous... A real life epilepsy story of Elena : tVNS in West and Aicardi Syndrome Discover the inspiring journey of Elena, a young girl with Aicardi syndrome and drug-resistant epilepsy, and the positive impact of tVNS... A real life epilepsy story of Oguzhan: tVNS in Dravet Syndrome and Resistant Epilepsy Zeliha Korkmaz, the mother of 7-year-old Oğuzhan, who battles resistant epilepsy and was diagnosed with Dravet syndrome at 4.5 months... Inspiring Insights and 2 coma recovery cases from Prof. Dr. Halil Özcan on Vagus Nerve Stimulation Professor Dr. Halil Özcan, shares insights on his 2 years tVNS experience and 2 coma recovery testimonials Contact Our Global tVNS Experts Worldwide Name Select inquiry: Choose an option Email : Country Please enter you message here Code Phone (optional) I have read and agree to the Privacy Policy Send Thanks for submitting!

tVNS Health Gmbh is a medical technology sales company based in Grünwald, Germany, that has been responsible for the global distribution, services, and operations management of tVNS devices. About Us tVNS Health Gmbh is a medical technology sales company based in Germany, responsible for the global distribution, services, and sales of tVNS® non-invasive auricular vagus nerve stimulation devices in Eastern Europe, Scandinavia, Asia, Africa, South America and Italy. The developer and manufacturer of tVNS® devices is tVNS Technologies GmbH based in Erlangen, Germany. Since the medical approval of the Cerbomed Nemos® device as a first non-invasive auricular vagus nerve stimulation medical device in 2010, Cerbomed Nemos® and the new tVNS® have been used in thousands of treatments globally and significantly improved patients' quality of life. Meet the Founders Berkay Gezen is an enthusiastic professional with 28+ global business development and medical brand management. He has served as the global commercial director of CardiAid, brand for 11 years, from the design of the brand to its expansion in over 65 countries of the world. Following his creative vision of AED and his experience in global development, he became the founder of tVNS Health to focus on neuromodulation and vagus nerve stimulation technologies, sales, services and distribution for tVNS. With his expertise in market building, he become the implementer of projects that make a difference in more than 80 countries of the world. He has dedicated his professional life to increasing the awareness of public access defibrillators and neuromodulation. With his motivation, he inspires the medical community and continues to manage medical channel in more than 50 countries worldwide. Selin Erdogan Gezen Selin Erdogan Gezen She is a visionary leader in the field of neuromodulation technologies and global business development. After pivotal roles in renowned companies like Vodafone, Garanti BBVA Bank, and Hewlett Packard, as program management in innovative technology projects, Selin embarked on a new chapter as a founding partner of Nervovita Medical Technologies and tVNS Health, focusing on neuromodulation therapies. Her dedication led to the accessibility of transcutaneous vagal nerve stimulation, revolutionizing treatment options around the globe. She collaborates with leading universities and institutes in over 40 countries, driving clinical studies across various diseases. She is designing the human-machine interaction for better usability of wearable medical devices. "Our mission is to empower individuals worldwide with innovative neuromodulation and bio-electronic solutions that enhance well-being and improve lives. Committed to advancing healthcare through cutting-edge technology, we strive to be the global leader in distributing the transcutaneous vagus nerve stimulation devices. Guided by a dedication to excellence, integrity, and social responsibility, our company aims to establish a pervasive presence in the global market, ensuring accessibility to the transformative benefits of the tVNS devices. We are driven by a passion for improving mental and physical health, fostering a world where individuals can achieve their full potential and lead fulfilling lives. Our commitment extends beyond the distribution; we aim to build enduring partnerships with healthcare professionals, research institutions, and distributors to foster a collaborative ecosystem. By prioritizing customer satisfaction, continuous innovation, and ethical business practices, we aim to create a positive impact on the well-being of communities around the globe." Our Mission Our Vision "We envision a future where transformative neuromodulation technology becomes an integral part of global healthcare, revolutionizing the way individuals manage and enhance their well-being. Guided by innovation, compassion, and a commitment to excellence, we aspire to establish ourselves as the foremost global influence, ensuring universal access, recognition, and trust in the widespread expansion of transcutaneous vagus nerve stimulation technologies (taVNS). We aspire to lead the charge in advancing the field of neuromodulation, continuously pushing the boundaries of what is possible to unlock the full potential of the human body's innate healing mechanisms. By fostering a culture of curiosity, collaboration, and inclusivity, we aim to inspire a global movement toward proactive and personalized healthcare solutions. Through strategic partnerships, ongoing research, and a commitment to ethical business practices, we seek to shape a healthcare landscape where preventative and holistic approaches are celebrated. As we strive for excellence, our vision extends beyond business success to contributing significantly to the betterment of society. We see a world where the neuromodulation becomes a beacon of hope, fostering resilience, and promoting a culture of well-being that transcends borders. We are dedicated to pioneering a future where the power of neuromodulation transforms lives, creating a healthier, happier, and more connected global community." tVNS Health GmbH Headquarter Südliche Münchner Str. 62, 82031 Grünwald, Germany info@tvns.health www.tvns.health Contact tVNS Health info@tvns.health Contact Form

tVNS, non-surgical treatment option for epilepsy. The most up-to-date health information about epilepsy causes, symptoms, treatment options Less seizures - more from life. Treat drug-resistant epilepsy wit h tVNS® Epilepsy An epileptic seizure is a clinical condition that occurs when the normal activity of the brain is disrupted by the temporary abnormal electrical acti vity in the nerve cells. Epilepsy is the recurrence of epileptic seizures and is considered a chronic disease. While anticonvulsants are commonly prescribed, many epileptic patients are resist ant to drug therapy. Treatment Options for Drug Resistant Epilepsy Epilepsy Surgery There are two methods of neurosurgery: removal of the brain region that causes seizures and surgical cutting of the neural pathways that cause seizures to spread. However, since these methods are only suitable for focal epilepsies, only a small proportion of epilepsy patients are suitable for this invasive procedure. In deep brain stimulation, electrodes are implanted in the brain. These electrodes are attached to a battery operated stimulator that is usually placed under the patient’s collarbone. Epileptic activity can be specifically affected at the baseline through current stimuli. Deep Brain Stimulation Invasive Vagus Nerve Stimulation In some patients, a treatment called “vagus nerve stimulation”, also known as brain pacemaker surgery, can be applied. With a surgical intervention, a battery is placed under the chest and an electrode wire is placed in the vagus nerve in the neck. With the help of the electrode, the vagus nerve is stimulated at regular intervals, which may reduce seizures. Transcutaneous Vagus Nerve Stimulation The tVNS® auricular vagus nerve stimulation device is a treatment option that provides vagus nerve stimulation through the ear with a smartphone-sized device and a special headset without any surgical intervention. From there, as with invasive vagus nerve stimulation, higher centers of the brain are activated, triggering an anticonvulsant effect. How does tVNS® treat epilepsy? In transcutaneous vagus nerve stimulation, mild electrical impulses are given to the cymba concha region in the outer auricle through a special ear electrode. These stimuli activate the vagus nerve, which passes directly under the skin in this region (auricular branch of the vagus nerve). The nerve first transmits these impuleses to the Nucleus Tractus Solitarius in the brain stem and are transmitted to many different regions of the diencephalon (midbrain) and cerebrum. These stimuli are also transmitted to the Norepinephrine (Noradrenaline) center, the Locus Coeruleus, and Serotonin center, the Dorsal Raphe nucleus. These transmitters affect one’s clarity, energy, and confidence. These 2 centers send these neurotransmitters to the entire brain, specifically to the parts that control thinking and feeling. more serotonin and norepinephrine are then sent to the Prefrontal Cortex and are inhibited in the Hippocampus and Anterior Thalamus regions, which reduces anxiety and panic. This mechanism causes the frequency or severity of seizures to be reduced or stopped entirely. tVNS has helped hundreds of patients suffering from epilepsy to reduce or completely eliminate their seizures and lead a more self-determined life, without the need for surgery. “It’s wonderful that with tVNS® I have found a therapy option that makes me feel better without needing surgery.” Katja S. from Munich